Shareholding disclosure

BNP PARIBAS SA

Declared position

Threshold

Fell below threshold

Timeline

Published

22.04.2021

Transaction

15.04.2021

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAL4K00075

Beneficial owner

BNP PARIBAS SA

Declared address

BNP PARIBAS SA, 75009 Paris

Franchissement de seuil à la baisse suite à la restitution en date du 15/04/2021 de 4,5 millions de titres empruntés.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

BNP PARIBAS SA

Vifor Pharma AG22.04.2021TAL4K00075

Disclosure summary

BNP PARIBAS SA disclosed a holding in Vifor Pharma AG that fell below the publication threshold, published by SIX Exchange Regulation on 22.04.2021, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

BNP PARIBAS SA disclosed a holding in Vifor Pharma AG, published on 22.04.2021.

Publication date22.04.2021

Transaction date15.04.2021

Issuing companyVifor Pharma AG

Beneficial ownerBNP PARIBAS SA

Declared addressBNP PARIBAS SA, 75009 Paris

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTAL4K00075

Conditions

Franchissement de seuil à la baisse suite à la restitution en date du 15/04/2021 de 4,5 millions de titres empruntés.

Source: SIX Exchange Regulation · Publication date: 22.04.2021

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open